Cargando…
Clinicopathological and Molecular Prognostic Classifier for Intermediate/High-Risk Clear Cell Renal Cell Carcinoma
SIMPLE SUMMARY: In this report, we identified biomarkers for tumor progression from tissue samples of intermediate/high-risk ccRCC. Using the molecular findings and the clinical data, we developed an improved prognostic model which could help to provide better individualized management recommendatio...
Autores principales: | Roldán, Fiorella L., Lozano, Juan J., Ingelmo-Torres, Mercedes, Carrasco, Raquel, Díaz, Esther, Ramirez-Backhaus, Miguel, Rubio, José, Reig, Oscar, Alcaraz, Antonio, Mengual, Lourdes, Izquierdo, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699125/ https://www.ncbi.nlm.nih.gov/pubmed/34944958 http://dx.doi.org/10.3390/cancers13246338 |
Ejemplares similares
-
Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma
por: Roldán, Fiorella L., et al.
Publicado: (2022) -
Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
por: Carrasco, Raquel, et al.
Publicado: (2022) -
Urinary cell microRNA-based prognostic classifier for non-muscle invasive bladder cancer
por: Ingelmo-Torres, Mercedes, et al.
Publicado: (2017) -
Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer
por: Carrasco, Raquel, et al.
Publicado: (2022) -
Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication
por: Carrasco, Raquel, et al.
Publicado: (2021)